$PL

Raymond John w sold $170K of PL (indirect holdings)

Raymond John w sold 6,494 indirectly-held shares of Planet Labs PBC (PL) at $26.16 ($0.17M total) on 2026-07-13 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Raymond John w
Published Jul 14, 2026, 9:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 14, 2026, 9:23 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$PL
Neutral
high confidence
Mentioned
$PL
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLNeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price ($26.1582), and post-transaction holdings (37,114 shares), under a pre-arranged 10b5-1 plan.

02

Market read

Traders may monitor for clustering of insider sales, but this single planned sale is unlikely to drive a material repricing.

03

What to watch

The transaction is indirect and under a 10b5-1 plan; without additional context (other sales, option exercises, or changes in holdings), it is hard to infer directionality.

Relevance 3/10Novelty 3/10Timing: Filed on 2026-07-14, covering a sale executed on 2026-07-13.

Background

The article is an SEC Form 4 insider transaction disclosure for Planet Labs PBC, reported by director Raymond John W.

Company-level read

Ticker impact

$PLNeutralHigh confidence
Context

Raymond John W, a Planet Labs director, sold 6,494 shares in an open-market transaction under a 10b5-1 plan, worth about $169.9K.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-only and small versus normal trading volume.

Evidence & confidence

The filing is an SEC Form 4 insider transaction with a pre-arranged 10b5-1 plan, and the disclosed value ($169.9K) is modest relative to typical market moves.

Market effects

No clear sector read-through; this is company-specific insider trading with no operational or guidance content.

None indicated.

None indicated.

Counterpoint

Even planned 10b5-1 sales can coincide with private views on valuation or liquidity needs, so some traders may treat it as mild bearish sentiment.

Key entities

  • Planet Labs PBC

    Subject of the Form 4 insider transaction disclosure.

  • Raymond John W

    Director who sold shares via an open-market transaction under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PLMed

Planet Labs PBC Q2 2027 Earnings Call Summary

Planet Labs PBC reported Q2 2027 revenue growth of 58% YoY, driven by Satellite Services and Defense sectors. Non-GAAP gross margins reached 59%. The company increased CapEx guidance to $100M-$115M for next-gen constellations and maintains $850M in cash. Management highlighted a $4B pipeline for Satellite Services and strategic expansion in Europe.

$PLHighAI 8/10

Planet Labs Shares Jump After Q2 Results Beat Expectations

Planet Labs (PL) reported Q2 2027 revenue of $116.1M, up 58% YoY, beating estimates. Adjusted EPS was $0.02, surpassing expectations. Defense and intelligence revenue rose 90% YoY. The company raised FY2027 revenue guidance to $430M-$441M. Shares rose 14.1% in pre-market trading.

$PLHighAI 8/10

Planet Labs Rallies 10% as Record Revenue Overrides Soft Q3 Guidance

Planet Labs (PL) stock rose 10% after reporting Q2 revenue of $116.1M, beating estimates by 11%, and adjusted EPS of $0.02, reversing a pre-earnings decline. Despite softer Q3 guidance, the company highlights a $4B sovereign satellite-services pipeline. Defense and intelligence revenue grew over 90% YoY, and non-GAAP gross margin was 59%.